Drug Type Synthetic peptide, Molecular glue |
Synonyms ST-0529, STI-0529 |
Mechanism Mitocliondrial permeability transition pore inhibitors, P-gp inhibitors(P-glycoprotein 1 inhibitors) |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC62H111N11O12 |
InChIKeyPMATZTZNYRCHOR-CGLBZJNRSA-N |
CAS Registry59865-13-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Phase 2 | - | - | |
Crohn Disease | Phase 1 | - | 27 Jan 2021 | |
Graft Rejection | Phase 1 | - | - | |
Graft vs Host Disease | Phase 1 | - | - | |
Psoriasis | Phase 1 | - | - |